Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Jesse McGreivy"'
Autor:
John Mascarenhas, Tania Jain, Salman Otoukesh, Aaron T. Gerds, Alessandro Lucchesi, Iberia Romina Sosa, Kamel Laribi, Elena Mishchenko, Atanas Radinoff, Giulia Benevolo, Alessandro M. Vannucchi, Francoise Boyer, Philippe Quittet, Markus Radsak, Antoine Machet, Prithviraj Bose, Zhuying Huang, Hope Qamoos, Jesse Mcgreivy, Wayne P. Rothbaum, Srdan Verstovsek, Francesco Passamonti
Publikováno v:
HemaSphere, Vol 7, p e72578ff (2023)
Externí odkaz:
https://doaj.org/article/8edee251cd8b493bbb10d982f407011f
Autor:
Pankit Vachhani, Andrew Perkins, John Mascarenhas, Haifa Kathrin Al-Ali, Jean-Jacques Kiladjian, Sonia Cerquozzi, Jaroslaw Dybko, Regina Garcia Delgado, Jesus Hernández Rivas, Holger Hebart, Zhuying Huang, Cecile Krejsa, Hope Qamoos, Jesse Mcgreivy, Wayne P. Rothbaum, Srdan Verstovsek, Alessandro Vannucchi
Publikováno v:
HemaSphere, Vol 7, p e05521ca (2023)
Externí odkaz:
https://doaj.org/article/261ee9a28228476d9e8db2a327ebc354
Autor:
John C. Byrd, Seema Ali Bhat, Farrukh Awan, Pratyush Giri, Sumita Ratnasingam, Roman Hájek, Dagmar Hess, Daniela Alves, Jan Maciej Zaucha, Annalise Shen, Elizabeth Bilotti, Jesse Mcgreivy, Wayne P. Rothbaum, Hanna Ciepluch
Publikováno v:
HemaSphere, Vol 7, p e197904a (2023)
Externí odkaz:
https://doaj.org/article/8da8cf41c62841f09bec7dcbf3d95b7f
Autor:
Michael Loschi, Laszlo Rejto, Hun Chuah, Marianna Caramella, Jesus Hernández Rivas, Paolo Sportoletti, Viviane Dubruille, Marcelo Bellesso, Stefanie Gröpper, Carl Crodel, Hope Qamoos, Ashley Socotch, Zhuying Huang, Sarah Wall, Jesse Mcgreivy, Wayne P. Rothbaum, Srdan Verstovsek, Francesca Palandri
Publikováno v:
HemaSphere, Vol 7, p e09624cd (2023)
Externí odkaz:
https://doaj.org/article/0a46ce546b8e4d0b96ceb07cce2d2232
Autor:
Andrzej Lange, Jesús María Hernández-Rivas, Regina Garcia Delgado, John Mascarenhas, Jesse McGreivy, Venu Valmeekam, Jean-Jacques Kiladjian, Haifa Kathrin Al-Ali, Pankit Vachani, Anne Uyei, Alessandro M. Vannucchi, Cecile M. Krejsa, Wayne P. Rothbaum, Andrew C. Perkins, Srdan Verstovsek
Publikováno v:
Blood. 138:3581-3581
Introduction Patients (pts) with MF who discontinue ruxolitinib due to resistance or progression have a poor prognosis (median OS, 14 months; Kuykendall et al. Ann Hematol. 2018). Available therapies provide symptom control and reduce spleen volumes,
Autor:
Srdan Verstovsek, Adam J. Mead, Alessandro M. Vannucchi, Jesse McGreivy, Jean-Jacques Kiladjian, Haifa Kathrin Al-Ali, John Mascarenhas, Wayne P. Rothbaum, Andrew C. Perkins, Anne Uyei
Publikováno v:
Journal of Clinical Oncology. 39:TPS7057-TPS7057
TPS7057 Background: The prognosis for patients (pts) with MF who have primary resistance to or who have progressed after treatment with ruxolitinib (RUX) is poor (median OS is ̃13 months), highlighting the unmet need for novel treatments in this set
Autor:
Jesse McGreivy, James A. DeCaprio, Ciara Marie Kelly, Wayne Rothbaum, Melissa Amber Burgess, Jaspreet Singh Grewal, Michael K.K. Wong, Anthony J. Olszanski, Karl D. Lewis, Hope Qamoos
Publikováno v:
Journal of Clinical Oncology. 38:10072-10072
10072 Background: MCC is an aggressive neuroendocrine skin cancer with very poor prognosis. Immune checkpoint inhibition was recently shown to benefit some patients (pts). There are few effective treatments (tx) and no standard of care for those who
Autor:
Jason Gotlib, Nashat Y. Gabrail, Wayne Rothbaum, Regina Garcia-Delgado, Timothy Sbardellati, Jesse McGreivy, Casey O'Connell, Claire N. Harrison, Jean-Jacques Kiladjian
Publikováno v:
Blood. 134:4168-4168
Background: Polycythemia vera (PV) is a myeloproliferative neoplasm (MPN) characterized by clonal stem cell proliferation of the erythroid, myeloid, and megakaryocytic lines. The predominant clinical characteristic is an increase in red cell mass, re
Autor:
Srdan Verstovsek, László Rejtő, Joanne Ewing, Eric Jourdan, Marek Hus, Jesse McGreivy, Philipp J. Jost, Wayne Rothbaum, Sebastian Grosicki, Holger Hebart, Regina Garcia-Delgado, Andrzej Pluta, Donal P. McLornan, Haifa Kathrin Al-Ali, Irum Khan
Publikováno v:
Blood. 134:2945-2945
Background: Myelofibrosis (MF) is a myeloproliferative neoplasm (MPN) characterized by progressive bone marrow fibrosis, ineffective erythropoiesis, dysplastic megakaryocyte hyperplasia, and extramedullary hematopoiesis. MF includes primary MF (PMF),
Autor:
Thomas M. Habermann, Chih Jian Lih, Ranjana H. Advani, Davina Moussa, Andre Goy, Paul M. Barr, Rebecca Elstrom, Nathan Fowler, Fong Clow, Betty Y. Chang, Maria Fardis, Darrin M. Beaupre, Brian Munneke, John F. Gerecitano, Ryan M. Young, Wyndham H. Wilson, Louis M. Staudt, Roland Schmitz, Stefania Pittaluga, Vaishalee P. Kenkre, Yandan Yang, P. Mickey Williams, George E. Wright, Andrei R. Shustov, Julie M. Vose, Jacqueline C. Barrientos, Jesse McGreivy, Sven de Vos, Arthur L. Shaffer, Kristie A. Blum
Publikováno v:
Nat Med
The two major subtypes of diffuse large B cell lymphoma (DLBCL)—activated B cell–like (ABC) and germinal center B cell–like (GCB)—arise by distinct mechanisms, with ABC selectively acquiring mutations that target the B cell receptor (BCR), fo